None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (a) spastic bilateral cerebral palsy between age 5 and 13, (b) level I or II according to GMFCS, (c) height over 100cm, (d) able to obey commands and conform to the study protocols.
Exclusion criteria
Exclusion criteria: (a) severe intellectual disability to obey the study protocol, (b) other types of cerebral palsy (e.g. dystonic or ataxic), (c) severe lower limb spasticity (Modified Ashworth Scale=3), or severe fixed joint contractures, (d) history of botulinum toxin injection or lower limb cast application within 3 months of study, (e) history of lower extremity orthopedic surgery within 6 months of study, (f) skin defects or diseases disabling the use of surface EMG, (g) presence of other musculoskeletal diseases (e.g. myopathy, osteomalacia, osteogenesis imperfecta).
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Onset and termination points of muscle activity during gait cycle | — |
Primary
| Measure | Time frame |
|---|---|
| Muscle activation pattern on surface electromyography | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital